rs150471537
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001355436.2(SPTB):c.3916C>T(p.Arg1306Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000656 in 152,350 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001355436.2 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPTB | NM_001355436.2 | c.3916C>T | p.Arg1306Ter | stop_gained | 19/36 | ENST00000644917.1 | NP_001342365.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPTB | ENST00000644917.1 | c.3916C>T | p.Arg1306Ter | stop_gained | 19/36 | NM_001355436.2 | ENSP00000495909 | P1 | ||
SPTB | ENST00000389722.7 | c.3916C>T | p.Arg1306Ter | stop_gained | 18/35 | 2 | ENSP00000374372 | P1 | ||
SPTB | ENST00000389720.4 | c.3916C>T | p.Arg1306Ter | stop_gained | 19/32 | 5 | ENSP00000374370 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152232Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251490Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135918
GnomAD4 exome Cov.: 33
GnomAD4 genome AF: 0.00000656 AC: 1AN: 152350Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74508
ClinVar
Submissions by phenotype
not provided Pathogenic:5
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 08, 2021 | For these reasons, this variant has been classified as Pathogenic. This variant has been observed in individual(s) with clinical features of spherocytosis (PMID: 29572776). This variant is present in population databases (rs150471537, ExAC 0.009%). This sequence change creates a premature translational stop signal (p.Arg1306*) in the SPTB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SPTB are known to be pathogenic (PMID: 8844207, 26830532, 27292444). - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jun 14, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2023 | SPTB: PVS1, PS4:Moderate, PM2:Supporting, PM6:Supporting - |
Pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Aug 29, 2023 | The SPTB c.3916C>T; p.Arg1306Ter variant (rs150471537) is reported in the literature in two individuals affected with hereditary spherocytosis (Mansour-Hendili 2020, Wang 2018). This variant is also reported in ClinVar (Variation ID: 544816). This variant is only observed on one allele in the Genome Aggregation Database, indicating it is not a common polymorphism. This variant induces an early termination codon and is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Based on available information, this variant is considered to be pathogenic. REFERENCES Mansour-Hendili L et al. Exome sequencing for diagnosis of congenital hemolytic anemia. Orphanet J Rare Dis. 2020 Jul 8. PMID: 32641076 Wang R et al. Exome sequencing confirms molecular diagnoses in 38 Chinese families with hereditary spherocytosis. Sci China Life Sci. 2018 Aug. PMID: 29572776 - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Aug 22, 2022 | PVS1, PM2 - |
Hereditary spherocytosis type 2 Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Department of Genetic, Henri Mondor Hospital, Assistance Publique des Hôpitaux de Paris | Feb 27, 2018 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Immunology and Genetics Kaiserslautern | Jan 30, 2023 | ACMG Criteria: PVS1, PM2, PP5; Variant was found in heterozygous state. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at